Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Walmart Inc Transportation Infrastructure U/S/ Economy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Tags Business Companies Biotechnology
From CNBC.com News
5 things to know before the stock market opens Wednesday
Tags Markets Politics Investment strategy
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Health & Science Social issues Health care industry
From CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Tags Social issues Health & Science Business
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
Tags Autozone Inc Entergy Corp Kinder Morgan
From CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Tickers NEWS NVO
Tags Zain Rizvi Diabetes Novo Nordisk
From Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
Tags Eli Lilly and Co US: News Biotechnology
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Roche Holding AG Pfizer Inc Health care industry
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Eli Lilly and Co Health & Science Social issues
From CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
Tags Alphabet Inc Retail industry Consumer Staples
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
Tickers JOBS
Tags Markets Oracle Corp Jobs
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Healthy Returns Social issues Apple Inc
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Technology Business News Economy
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Europe Markets Business Markets
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Health care industry Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Breaking News: Technology Breaking news Companies
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Health care industry Companies Breaking news
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Breaking News: Politics Health care industry Social issues
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Health care industry AstraZeneca PLC Novartis AG
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Health & Science Eli Lilly and Co
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Breaking news Companies Health care industry
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Health & Science Biotechnology Business
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Healthy Returns Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Eli Lilly and Co Biotechnology Business
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags US: News Eli Lilly and Co Biotechnology
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.